A novel synthetic DNA vaccine offers complete protection from Zaire Ebolavirus infection in promising preclinical research.
Congo's health ministry is preparing to begin Ebola vaccinations Wednesday, August 8, in the eastern city of Beni and neighboring Mangina village.
Researechers compared immune responses induced by Ebola virus glycoprotein subunit vaccines via intradermal immunization with microneedle (MN) patches and the conventional intramuscular injection in mice.
On 21 May, officials launched a vaccine trial with no untreated group as a control. Workers gave shots in four different locations to about 3300 people who had come in direct or secondhand contact with a confirmed case.
Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus.
Even if the vaccine helps, there are serious hurdles. The shots must be transported deep into forests with few paved roads without it spoiling in the heat, and health workers must identify and track down anyone who's had contact with a sick person and persuade them that shots pushed by foreigners could save their lives.
China is making a bid to use its Ebola vaccine in the Democratic Republic of the Congo.
Vaccine development is a complex process. It involves both public and private partners and requires that a variety of funding issues be considered.
With one vaccine already being used in the field, plans are underway to see if another might also be tested. And as many as five drugs could be used in head-to-head trials.
Based loosely on the dewars that industrial applications use to contain things like liquid nitrogen, the Arktek is a double-walled vessel with near-vacuum in between, held together with reinforced fiberglass.